Skip to content

Comment on Questcor Finds Profits, at $28,000 a Vial

Comments

> it raised the price overnight, to more than $23,000 a vial, from $1,650, bringing the cost of a typical course of treatment for infantile spasms to above $100,000.

> we only have about 800 patients a year

> Sales ... totaled nearly $350 million in the first nine months this year, up 145 percent from the period a year earlier

The counter-intuitive lesson is that charging vastly higher prices don't necessarily hurt sales.

AboutSource Built by g1lg1l

Hackerly is an independent reader for Hacker News, built on the public HN API. Not affiliated with Y Combinator.